|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.000 (0.000%) Non-current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,079 | 98.711% | 543 | 944 | 495,717 | 222,367 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 25,998 |
| Intangible Assets | 0 | -- | 0 | 195 | 158,985 | 160,835 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 312,960 | 277,013 | 277,936 |
| Other Non-current Assets | 315,112 | -0.704% | 317,347 | 2,746 | 569 | 521 |
| 316,191 | -0.534% | 317,890 | 316,845 | 932,284 | 687,657 | |
Current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 449 | 167.262% | 168 | 0 | 10,318 | 32,005 | |
| Trade Receivables | 8,732 | -- | 0 | 10,052 | 33,666 | 12,452 | |
| Cash & Bank Balances | 4,634 | -51.845% | 9,623 | 1,520 | 5,931 | 9,443 | |
| Other Current Assets | 14,404 | 125.274% | 6,394 | 705 | 23,519 | 33,803 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 180,000 | |
| 28,219 | 74.353% | 16,185 | 12,277 | 73,434 | 267,703 | ||
Current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 6,956 | 1296.787% | 498 | 974 | 8,477 | 44,630 | ||
| S-T Debt & Leases | 316,348 | -13.998% | 367,836 | 341,342 | 825,991 | 618,430 | ||
| Other Current Liabilities | 297,608 | -16.574% | 356,731 | 322,771 | 335,225 | 232,913 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 620,912 | -14.365% | 725,065 | 665,087 | 1,169,693 | 895,973 | |||
| Net Current Assets | (592,693) | -16.390% | (708,880) | (652,810) | (1,096,259) | (628,270) | ||
| Total Assets Less Current Liabilities | (276,502) | -29.282% | (390,990) | (335,965) | (163,975) | 59,387 | ||
Non-current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 375 | -95.381% | 8,118 | 3,600 | 463 | 213,680 | |||
| Other Non-current Liabilities | 0 | -- | 0 | 0 | 77,220 | 57,082 | |||
| 375 | -95.381% | 8,118 | 3,600 | 77,683 | 270,762 | ||||
Capital and Reserves
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 1 | 0.000% | 1 | 1 | 1 | 1 | ||||
| Reserves | (276,878) | -30.626% | (399,109) | (339,566) | (241,659) | (211,376) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | (276,877) | -30.626% | (399,108) | (339,565) | (241,658) | (211,375) | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| (276,877) | -30.626% | (399,108) | (339,565) | (241,658) | (211,375) | |||||
Commitments and Contingent Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | -- | 1,440 | 20,000 | 20,000 |
| Contingent Liabilities | -- | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 12/08/2025 07:42 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -53,357 |
| %Change | -62.841% |
| EPS / (LPS) | RMB -0.202 |
| NBV Per Share (¥) | RMB -1.511 |